SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-024729
Filing Date
2020-05-12
Accepted
2020-05-12 17:06:31
Documents
49
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q life-10q_20200331.htm 10-Q 1747327
2 EX-3.3 life-ex33_130.htm EX-3.3 11100
3 EX-31.1 life-ex311_8.htm EX-31.1 9624
4 EX-31.2 life-ex312_9.htm EX-31.2 9123
5 EX-32.1 life-ex321_6.htm EX-32.1 5500
6 EX-32.2 life-ex322_7.htm EX-32.2 5489
  Complete submission text file 0001564590-20-024729.txt   5539327

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT life-20200331.xml EX-101.INS 1080320
8 XBRL TAXONOMY EXTENSION SCHEMA life-20200331.xsd EX-101.SCH 43301
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE life-20200331_cal.xml EX-101.CAL 41574
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE life-20200331_def.xml EX-101.DEF 167343
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE life-20200331_lab.xml EX-101.LAB 349825
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE life-20200331_pre.xml EX-101.PRE 261472
Mailing Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121 858-731-8389
aTYR PHARMA INC (Filer) CIK: 0001339970 (see all company filings)

IRS No.: 203435077 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37378 | Film No.: 20869979
SIC: 2836 Biological Products, (No Diagnostic Substances)